Release Date: 05/08/14 09:40 Summary: Response to MetroCoal announcement Price Sensitive: No Download Document 89.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%